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Edited by Frances ShannonAbstract MLL is involved in the process of gene activity main-
tenance. It is shown that the amino-terminal region of MLL
(MLLN) interacts with TAF-Ib/SET. In this study, using yeast
two-hybrid assays, we have found that the acidic region of
TAF-Ib is essential for its binding to MLLN. Pull-down assays
using GST-MLLN demonstrated that TAF-Ib and histones
interact with GST-MLLN. MLLN and TAF-Ib synergistically
upregulated the transcription level of Hoxa9 and co-immunopre-
cipitated in chromatin containing the Hoxa9 promoter region.
These results suggest that TAF-Ib plays an important role in
MLL-mediated transcription and possibly chromatin
maintenance.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The human MLL (mixed lineage leukemia) protein contains
a region that is structurally and functionally homologous to
that of trithorax (Trx), a Drosophila homeotic regulator, which
is considered to be involved in the process of gene activity
maintenance (reviewed in [1]). The MLL gene encodes a
3969 amino acid (aa) nuclear protein that has multiple func-
tional domains including three AT-hooks at the N-terminal re-
gion, two repression domains (RD1 and RD2), PHD ﬁngers, a
transactivation domain, and SET domain in the C-terminal re-
gion (Fig. 1A). Studies with cells that express the domains of
interest are increasing our knowledge on the molecular func-
tion of MLL. RD1 and RD2 recruit the Polycomb group pro-
teins and histone deacetylases, respectively [2], while PHD
domains interact with Cyp33 [3]. The transactivation domain
and SET domain are shown to directly bind to CBP and the
components of SWI/SNF complexes, respectively [4,5]. It was
shown that the SET domain possesses the histone methyltrans-
ferase activity of histone H3 at Lys 4 (H3–K4) [6,7]. These re-
sults suggest that MLL is involved in gene activation through*Corresponding author. Fax: +81 29 853 3233.
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doi:10.1016/j.febslet.2004.12.064its histone modiﬁcation ability and by interaction with various
proteins involved in coactivation of transcription, ATP-depen-
dent chromatin remodeling, and histone modiﬁcation. We
have attempted to focus this study on the functional role
associated with the N-terminal region of MLL containing
AT-hooks (designated MLLN). Overexpression of MLLN
upregulates the expression of p21cip and p27kip genes [8]; how-
ever, the mechanism by which MLLN regulates the expression
of these genes is not well clariﬁed. In vitro pull-down assays
showed that MLLN interacts with TAF-I (Template Activat-
ing Factor-I), a histone chaperone [9]. In an in vitro replication
system, TAF-I proteins were identiﬁed as stimulatory factors
for replication in the adenovirus (Ad) genome complexed with
viral basic proteins (Ad core) [10]. Depending on its acidic re-
gion, TAF-I causes structural change in not only the Ad core
but also in the cellular chromatin [11,12]. It is reported that
TAF-I is included in INHAT (inhibitor of acetyl transferases)
complexes [13]. These observations suggest that TAF-I is in-
volved in chromatin regulation. Since the functional signiﬁ-
cance of the interaction of MLLN with a histone chaperone
is not well understood, we tested whether MLLN is involved
with TAF-Ib in the process of activation of target genes.2. Materials and methods
2.1. Construction of plasmids
pGAD424 carrying the activation domain of GAL4 and pBTM116,
a LexA-based vector that contains the yeast TRP1 gene, were used [15]
for the yeast two-hybrid system [14]. In order to construct pGAD424
containing TAF-Ib (a subtype of TAF-I) and its derivatives, pET14b
vectors containing the corresponding cDNAs [10,16] were digested
with NdeI and EcoRI. The DNA fragments were blunted and cloned
into the SmaI site of pGAD424. A DNA fragment encoding MLLN
(between aa positions 110 and 405 of MLL) was generated by PCR
with MLL cDNA as the template and the oligonucleotide primers,
5 0-CTCCGGCATATGCCGGGCTTCGACGCGGCG-3 0 and 5 0-
GCCTGCAGAACAGGCATGATGAACTGTCG-3 0. PCR products
were digested with NdeI and SspI, blunted, and cloned into the SmaI
site of pBTM116 and pGEX-2T. A DNA fragment encoding MLLN
was generated by PCR using MLL cDNA as the template and the
oligonucleotide primers, 5 0-CTCCGGCATATGCCGGGCTTC-
GACGCGGCG-3 0 and 5 0-AGGCATGATGAACTCGAGCTAATT-
TTTGAC-30. PCR products were digested with NdeI and XhoI, and
then ligated into NdeI- and XhoI-digested pBS-Flag [16]. This plasmid
was digested with SspI and XhoI, and blunted. DNA fragments were
ligated into EcoRV and XhoI-digested and Klenow-treated pCHA
[17] in order to generate a eukaryotic expression vector encoding
Flag-MLLN.blished by Elsevier B.V. All rights reserved.
Fig. 1. Interaction of MLLN with TAF-Ib. (A) Schematic represen-
tation of functional domains of MLL and TAF-Ib. (B) Yeast two
hybrid assays were carried out with MLLN, including a TAF-I binding
site as a bait protein using yeast strain L40. The b-galactosidase
activity was measured in each of the three separate yeast clones, and
the average activities with standard deviation were calculated and
plotted.
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293T cells (1 · 106) were transfected with plasmid DNAs (total
amount of 6 lg) using the TransIT transfection reagent (TaKaRa).
Chromatin immunoprecipitation was carried out essentially according
to the protocol from Upstate. In order to detect the recovered DNA, it
was ampliﬁed by PCR with the primer sets, 5 0-GGGAGACGG-
GAGAGTACAGA-30 and 5 0-GTCCAGCAGAACAATAACGC-30
and 5 0-AACTCAGGCTACCAGCAGAA-3 0, and 5 0-GTCCTTC-
GCTACTGTTAGTG-3 0, corresponding to Hoxa9 and Hoxc8, respec-
tively. Two primer sets for Hoxa9 and Hoxc8 covered those regions of
their sequence that contained functionally important methylated his-
tone binding sites [6].Fig. 2. Subcellular distribution of transiently expressed MLLN and
TAF-Ib in HeLa cells. HeLa cells were transfected with plasmids
encoding Flag-MLLN (a–c), HA-TAF-Ib (d–f), both Flag-MLLN and
HA-TAF-Ib (g–j), and both Flag-MLLN and HA-TAF-IbDC3 (k–n).
After 48 h post-transfection, cells were subjected to indirect immuno-
ﬂuorescence staining. Flag-MLLN and HA-TAF-Ib were detected
using anti-Flag (M2) monoclonal antibody (Sigma; b, h, and l), and
with anti-HA polyclonal antibody (MBL; e, i, and m), respectively.
The goat anti-mouse Ig conjugated with Alexa488 and the goat anti-
rabbit Ig conjugated with Alexa568 (Molecular probe) were used as
secondary antibodies. DNA was stained with DAPI (a, d, g, and k).
Staining patterns of DAPI (blue), Flag-tag (green), and HA-tag (red)
were merged (c, f, j, and n). A scale bar indicates 10 lm.3. Results
3.1. In vivo interaction of MLLN with TAF-Ib
MLL encodes a nuclear protein of 3969 aa that has multiple
domains (Fig. 1A). A yeast two-hybrid assay shows that
MLLN interacts with TAF-Ib [9]. TAF-I proteins consist of
N-terminal subtype speciﬁc regions, a coiled-coil region in-
volved in dimerization of TAF-I, and a long acidic region
essential for its chromatin remodeling activity [10,16] (Fig.
1A). We performed yeast two-hybrid assays with MLLN and
TAF-Ib derivatives in order to identify a domain(s) of TAF-
Ib that is required for the interaction with MLLN. MLLN
and one of the TAF-Ib proteins were coexpressed in Saccharo-
myces cerevisiae strain L40 and then subjected to b-galactosi-
dase activity assays (Fig. 1B). TAF-Ib and TAF-IDN1
lacking the N-terminal b-speciﬁc region showed high b-galac-
tosidase activity levels. TAF-IbDC3 lacking the C-terminal
acidic region and TAF-Ib PME lacking dimerization abilityled to b-galactosidase expression, which was as low as the
background level. These results indicate that the acidic region
and the dimerization domain of TAF-Ib are essential for its
binding to MLLN.
To further study the in vivo interaction between MLLN and
TAF-Ib, the subcellular localization of MLLN and TAF-Ib
was examined by immunoﬂuorescence staining (Fig. 2). Flag-
MLLN was mainly detected in the nucleolus when it was
expressed alone. In contrast, on co-expression with HA-
TAF-Ib, Flag-MLLN was distributed throughout the nucleus.
However, Flag-MLLN was found in both the nucleolus and
the nucleoplasm in cells co-expressing HA-TAF-IbDC3 lack-
ing the C-terminal acidic region, which is important for bind-
ing to MLLN (Fig. 1B). These results support the notion that
MLLN interacts with TAF-Ib in vivo and that the C-terminal
acidic region of TAF-Ib is involved in this interaction.
3.2. In vitro interaction of MLLN with TAF-Ib
To further study the interaction between MLLN and TAF-
Ib, in vitro pull-down assays were carried out with bacterially
expressed GST-MLLN. HeLa whole cell lysates were added to
puriﬁed GST-MLLN or GST on glutathione sepharose 4B
beads; subsequently, TAF-Ib and histone H3 and core histones
on beads were detected by Western blotting and silver staining,
respectively. Fig. 3A indicates the interaction of GST-MLLN
with TAF-Ib and histone H3. Silver staining revealed the
recovery of core histones with GST-MLLN. The amount of
pulled-down histone H3/H4 exceeded that of histone H2A/
H2B. Since TAF-I interacts preferentially with H3/H4 rather
than H2A/H2B [12], it is assumed that GST-MLLN would
bind to TAF-Ib-histone H3/H4 complexes. Alternatively,
Fig. 3. GST pull-down. (A) Interaction of GST-MLLN with TAF-Ib and histones in cell lysates. Bacterially expressed GST-MLLN was puriﬁed
with glutathione sepharose beads (Pharmacia Biotech) according to the manufacturers instructions. GST-MLLN (500 ng) on beads was incubated in
the absence (lanes 1 and 5) or presence of 10 lg (lanes 2 and 6), 30 lg (lanes 3 and 7), and 100 lg (lanes 4 and 8) of HeLa cell lysates. Proteins on
beads were detected by Western blotting with mouse anti-TAF-Ib monoclonal antibody [17] and rabbit anti-histone H3 polyclonal antibody
(Abcam). Core histones were shown by silver staining. Lane 9 shows the input level of TAF-Ib and histone H3 present in 10 lg of HeLa whole cell
lysate. (B) In vitro interaction of MLLN with rTAF-Ib and core histones. Core histones and rTAF-I proteins were prepared as previously described
[10,12,16]. Puriﬁed GST-MLLN (500 ng) on beads were simply mixed with TAF-Ib (500 ng) or core histones. After incubation at 4 C for 1 h, protein
complexes on beads were washed with the binding buﬀer (12.5 mM MgCl2, 0.1 mM EDTA, and 20 mM HEPES, pH 7.9) containing 50, 300,
500 mM, and 1 M NaCl (lanes 1, 2, 3, and 4, respectively). Proteins on beads were detected by western blotting. Lanes 5 shows 5 ng of TAF-Ib and
250 ng of core histones.
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histones with a binding preference for histone H3/H4. As the
next step, pull-down assays were carried out with recombinant
TAF-Ib (rTAF-Ib) puriﬁed from lysates of E. coli cells con-
taining pET-TAF-Ib [16] and core histones prepared from
HeLa cells [12,18] (Fig. 3B). Proteins were added to puriﬁed
GST-MLLN on beads and the beads were washed with buﬀer
containing various concentrations of NaCl. TAF-Ib and his-
tone H3 bound to GST-MLLN were detected by Western blot-
ting. GST-MLLN bound to TAF-Ib and the binding was
resistant to 1 M NaCl (lane 4). The binding of GST-MLLN
to histone H3 was resistant to the wash with 300 mM NaCl
and partly resistant to 500 mM NaCl, while it was destroyed
in 1 M NaCl (lanes 3 and 4). Essentially the same binding
mode was observed, irrespective of simultaneous addition or
order of addition of TAF-Ib and histones (data not shown).
The binding of TAF-I to core histones was resistant to
300 mM NaCl; however, it was eliminated in 500 mM NaCl
(data not shown). Considered collectively, it is concluded that
histones as well as TAF-Ib can directly bind to GST-MLLN,
although it is not clear whether MLLN binds to TAF-Ib and
histones independently and/or interdependently under a cer-
tain physiological state.
3.3. Synergistic activation of Hoxa9 gene transcription by
MLLN and TAF-Ib
It is well known that the transcription of Hoxa9 is activated
by MLL. In order to explore the functional role of the interac-
tion of MLLN with TAF-Ib, the eﬀect of both proteins on the
transcription of the Hoxa9 gene was analyzed. HeLa cells weretransfected with pCAGGS-Flag-MLLN and pCHA-TAF-Ib,
and the amount of Hoxa9 mRNA was measured by RT-
PCR (Fig. 4A). TAF-Ib upregulated the transcription level
of Hoxa9 (lanes 1–3 and 7–9), while MLLN alone did not en-
hance the transcription (lanes 1, 4, 7, and 10). It was notewor-
thy that MLLN and TAF-Ib synergistically stimulated the
transcription level of Hoxa9, while they do not aﬀect the tran-
scription of b-actin (lanes 4–6 and 10–12). In Fig. 4B, semi-
quantitative RT-PCR assays conﬁrmed the eﬀect of MLLN
and TAF-Ib on the transcriptional levels of Hoxa9. Thus,
the transcription of both Hoxa9 was stimulated by MLLN
and TAF-Ib.
Immunoprecipitation assays were carried out to conﬁrm the
in vivo interaction of MLLN with TAF-Ib (Fig. 5A). Cell ly-
sates were incubated with either anti-HA antibody or anti-Flag
antibody. Immunocomplexes isolated with anti-Flag antibody
were shown to contain both HA-TAF-Ib and Flag-MLLN,
and both proteins were found in immunocomplexes with
anti-HA antibody. Finally, chromatin immunoprecipitation
assays were carried out to examine whether MLLN and
TAF-Ib reside in the chromatin complex of the Hoxa9 gene
(Fig. 5B). MLLN was found to be present in Hoxa9; the
amount of MLLN in Hoxa9 was found to be 2–4 times more
when TAF-Ib was simultaneously expressed with MLLN than
when MLLN was expressed alone (lanes 5 and 11). Thus,
MLLN is present with TAF-Ib inHoxa9.Hoxc8 is also known
as the target of MLL [6]. As is the case forHoxa9, TAF-Ib and
MLLN activated transcription of Hoxc8 (data not shown).
Chromatin immunoprecipitation assays were carried out on
Hoxc8, and MLLN is present with TAF-Ib in Hoxc8 in the
Fig. 4. Synergistic activation of Hoxa9 gene transcription by MLLN and TAF-Ib. (A) After 48 h post-transfection, total RNA was isolated from
HeLa cells (1 · 106) transfected with 3 lg (lanes 2, 5, 8, and 11) or 6 lg (lanes 3, 6, 9, and 12) of pCHA-TAF-Ib, 12 lg of pCAGGS-FlagMLLN
(lanes 4–6 and 10–12), and pCAGGS as a buﬀer empty vector (so as to be a total amount of 18 lg of DNA). RNA (1 lg) was subjected to reverse
transcription with oligo dTs as primer, and 1/50 of cDNA was used for the PCR ampliﬁcation as template in the presence of primer sets, 5 0-
TACGTGGACTCGTTCCTGC-3 0 and 5 0-GTGGTGATGGTGGTGGTACA-30 for Hoxa9 and 5 0-ATGGGTCAGAAGGATTCCTATGT-3 0 and
5 0-AGCCACACGCAGCTCATT-3 0 for b-actin (30 cycles for Hoxa9 and 20 cycles for b-actin (lanes 1–6), or 35 cycles forHoxa9 and 25 cycles for b-
actin (lanes 7–12)). A sample prepared without reverse transcriptase (lane 13) and HeLa genomic DNA (2.5 · 102 cell equivalents) (lane 14) were also
PCR-ampliﬁed. (B) cDNA prepared from HeLa cells transfected control vector (lane 4), HA-TAF-Ib expression vector (lane 5; 2 lg DNA), Flag-
MLLN expression vector (lane 6; 10 lg of DNA), and HA-TAF-Ib and Flag-MLLN expression vectors (lane 7; 2 and 10 lg DNA, respectively) were
ampliﬁed in the presence of the primer set for Hoxa9 gene. A sample prepared without reverse transcriptase (lane 8) and HeLa genomic DNA (lanes
1–3, 2.5 · 10, 7.5 · 10, and 2.5 · 102 cell equivalents, respectively) were also PCR-ampliﬁed. PCR cycles (34, 36, and 38) are indicated.
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question of the eﬀect of MLLN lacking domains involved in
histone methylation on the histone methylation status, possi-
bly by means of endogenous MLL. In order to assess the meth-
ylation status of histone H3 in Hoxa9 chromatin,
immunoprecipitation assays using anti-dimethylated histone
H3 at Lys4 (H3–K4) were performed. These analyses showed
that the methylation level of the H3–K4 of Hoxa9 was
unchanged irrespective of the expression of MLLN and
TAF-Ib, suggesting that the eﬀect of MLLN with TAF-Ib is
independent of endogenous MLL and its SET domain. The
same results were obtained for Hoxc8. Considered collectively,
we propose that the transcriptional activation by MLLN is
independent of the MLL SET domain.4. Discussion
The Trx group proteins are considered to be involved in the
maintenance of the gene transcription level. Experiments with
MLL knockout mice and cells indicate that MLL is required
for the maintenance of gene expression during early embryo-
genesis [19], hematopoietic diﬀerentiation in vitro [20], and dif-
ferentiation of myeloid and macrophage cells from early
hematopoietic progenitors [21]. The molecular function of
MLL has been analyzed using cells expressing the domains
of interest. The C-terminal SET domain methylates histone
H3–K4 at the promoter region of the Hox gene [6], suggesting
that the SET domain is involved in the maintenance of an ac-
tive state of the Hox gene. However, the ectopically expressing
MLL lacking the SET domain was capable of partially restor-
ing the transcription level ofHoxa9 in MLL knockout lines [6].
In addition, the Hoxa9 expression is maintained in myeloid
cells containing an MLL protein consisting of only 1300 aacorresponding to the N-terminal portion [22]. These results
suggest that domains other than those involved in histone
modiﬁcation play important roles in maintaining the gene
transcription level.
It was reported that MLLN binds to TAF-Ib [9], one of the
histone chaperones. Therefore, we attempted to study the
cooperation between MLLN and TAF-I. In this study, we ﬁrst
examined the mode of interaction of MLLN with TAF-I. In
yeast two hybrid assays, it was shown that TAF-Ib, but neither
TAF-IbDC3 nor TAF-Ib PME, does interact with MLLN
(Fig. 1B). Transfection experiments have shown that MLLN
is mainly localized in the nucleolus. However, TAF-Ib but
not TAF-IbDC3 alters the subcellular localization of MLLN
in the nucleoplasm (Fig. 2). It was previously reported that
the acidic region of TAF-I and dimerization are required for
the TAF-I activity in the Ad core DNA replication assay
[16]. These observations suggest that both the dimerization do-
main and the acidic region of TAF-I are important for its bind-
ing to basic proteins such as histones and Ad core proteins.
Results shown in Figs. 2 and 3 indicate that TAF-I binds to
MLLN in a manner similar to its binding to basic proteins.
Using in vitro binding assays, we found that TAF-Ib and his-
tone H3 bind to MLLN (Fig. 3). We had assumed the possibil-
ity that MLLN may bind to histones to which TAF-I would
bind, thereby leading to the formation of MLLN–histones–
TAF-I complexes. However, TAF-Ib and core histones inde-
pendently interact with MLLN under a certain physiological
condition, and the interaction is resistant to 500 mM NaCl, a
condition under which TAF-I cannot interact with histones
(data not shown). This suggests that TAF-Ib interacts with
MLLN in the presence or absence of histones under a certain
physiological condition. In light of this, TAF-I and MLLN
may not compete in terms of their binding to histones. This
dual binding ability of TAF-I may allow TAF-I to target
Fig. 5. (A) Immnoprecipitation. Cell lysates prepared from 293T cells
expressing Flag-MLLN and HA-TAF-Ib were incubated with rabbit
preimmune serum (lane 2), anti-Flag M2 (lane 3), or anti-HA
monoclonal antibody (Roche) (lane 4). MLLN and TAF-Ib bound
to Ig-protein A sepharose beads were detected by Western blotting
with anti-Flag M2 and anti-HA, respectively. Input lane includes 1/10
of lysates used for the experiment. (B) Chromatin immunoprecipita-
tion. Cell lysates prepared from cross-linked 293T cells expressing
Flag-MLLN and/or HA-TAF-Ib were incubated with rabbit pre-
immune serum (lanes 4 and 10), anti-Flag M2 (lanes 5 and 11), and
anti-dimethyl histone H3–K4 (Abcam) (lanes 6 and 12), respectively.
The genome DNA was puriﬁed from immuno-complexes and sub-
jected to ampliﬁcation by PCR. Input (lanes 1–3) shows PCR product
from DNA recovered from 1/500, 1/150, and 1/50 of cell lysates used
for the experiment, respectively.
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gene and to simultaneously function there as a histone binding/
chaperone protein. Moreover, since TAF-I is capable of medi-
ating both the association and dissociation of basic proteins to
and from DNA [11,12], there may be a regulatory factor(s)
and/or a mechanism switching this dual activity.
The MLL gene is known to be associated with a variety of
chromosomal translocations found in acute myeloid and lym-
phoid leukemia. The N-terminal AT-hooks, RD1, and RD2
are present in all types of MLL fusion proteins. An in vitro
transformation experiment revealed that MLLN is required
for the transformation capacity of an MLL fusion protein
[23]. It was also reported that induced dimerization of a trun-
cated MLL immortalizes bone marrow cells and imposes a
reversible block on myeloid diﬀerentiation associated withupregulation of Hoxa9 [24]. These ﬁndings suggest that a
dimerized MLL fusion protein outcompetes the unrearranged
form of MLL for binding to target DNAs and proteins. In this
study, we have shown that TAF-Ib and MLLN synergistically
upregulated transcription of the Hoxa9 gene, and MLLN was
present in the promoter region of Hoxa9 (Figs. 4 and 5). Thus,
TAF-Ib may be one of the important candidate. In any case, it
is important to clarify the role of TAF-Ib with the full-sized
MLL in chromatin maintenance.
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